Glatiramer Acetate Therapy: The Plot Thickens Glatiramer Acetate Therapy: The Plot Thickens2018-01-17T17:04:28-05:00
A prospective, open-label treatment trial to compare the effect of IFN b-1a (Avonex), IFNb-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis A prospective, open-label treatment trial to compare the effect of IFN b-1a (Avonex), IFNb-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis2018-01-17T17:04:28-05:00
Statins as immunomodulators; Comparison with interferon-β1b in MS Statins as immunomodulators; Comparison with interferon-β1b in MS2018-01-17T17:04:28-05:00
Altered CD4 /CD8 T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis Altered CD4 /CD8 T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis2018-01-17T17:04:28-05:00
Therapy with glatiramer acetate for multiple sclerosis Therapy with glatiramer acetate for multiple sclerosis2018-01-17T17:04:23-05:00
Treatment of Multiple Sclerosis with the Pregnancy Hormone Estriol Treatment of Multiple Sclerosis with the Pregnancy Hormone Estriol2018-01-17T17:04:23-05:00
Economic evaluation of Avonex† (interferon beta-1a) in patients following a single demyelinating event Economic evaluation of Avonex† (interferon beta-1a) in patients following a single demyelinating event2018-01-17T17:04:16-05:00
Treatment of severe autoimmune disease by stem-cell transplantation Treatment of severe autoimmune disease by stem-cell transplantation2018-01-17T17:04:11-05:00
